Heckman: Bunge entering the ‘fun’

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
331
Heckman: Bunge entering the ‘fun’ stage
https://www.world-grain.com/articles/16204-he...-fun-stage

ST. LOUIS, MISSOURI, US — After two years of reorganizing, rightsizing the portfolio and getting the balance sheet where it needs to be — the so-called “fix” phase, Bunge Ltd. is ready to embark on the “growth” phase, said Gregory A. Heckman, chief executive officer.

The fix phase, Heckman said, was all about growing earnings and improving the underlying earning power of the business to grow off of. In the growth phase, Bunge gets to focus on expanding its footprint and building out its capabilities.

With the right network, operating model and people, Bunge is now positioned to “get maniacally focused externally,” Mr. Heckman said. This next phase for Bunge will mean “pulling every growth lever,” he added.

Specifically, Heckman said all options are on the table for growth, including organic projects, brownfield projects, greenfield projects and mergers and acquisitions of all sizes.

“Those are all open to us, and we’ll let the numbers drive where we should go,” he said.

He said M&A and debottlenecking will get to the ground more quickly, while brownfield and greenfield projects will take some time to yield contributions to earnings.

“But if you look at the refined and specialty oils platform … we’ve got the ability now to margin up some of the things that we did in commodities before,” he explained. “None of them are big, but they’re all in our adjacencies, right? So, the lecithins and the tocopherols and some of the things that we’re doing in infant nutrition also work in … senior nutrition and sports nutrition. We continue to move the ball on all those things. And as we make progress, those are all places that fit for organic investment and/or bolt-on acquisitions.”

On the plant protein side, Bunge is serving its customers and finding success with lipids, Heckman said. He also said the company has invested in its Creative Solutions Center to be able to work with not only its lipids, but also its plant proteins, and in many cases is working with customers to put those two products together.

“So as we work with those customers backwards, many of those names you know today on the existing CPGs and some of those on the disruptors and the new customers, helping them because they’re worried about long term when they see their own demand forecast that they’re going to have enough supply,” he said.

Heckman said Bunge has made some minority investments to gain access to technology and has looked at larger M&As, although the latter have traded at high prices. The plan, though, is to stay disciplined, he said.

“We think we’ll probably create value there by doing something on the brownfield or greenfield side, when it makes sense and to grow with those customers over time,” he said. “So the plant protein will be a longer build. We’ll enjoy that in the lipids now, we’ll enjoy the plant protein piece later.”

Bunge also remains fully engaged in its biggest business — supplying renewable feedstocks, including both products and services, Mr. Heckman said.

He said the company is looking at all the opportunities going forward on its renewable fuel joint venture formed in September with the Chevron Corp. As part of the JV, Bunge is expected to contribute its soybean processing facilities in Destrehan, Louisiana, US, and Cairo, Illinois, US. Chevron, San Ramon, California, US, is expected to contribute about $600 million in cash to the joint venture, which aims to establish a reliable supply chain from farmer to fueling station for both companies. The two companies anticipate approximately doubling the combined capacity of the facilities to 7,000 tons per day by the end of 2024.


Heckman: Bunge entering the ‘fun’ stage
Bunge_North-America-HQ_Photo-cred-Bunge_E.jpg
Photo courtesy of Bunge.

12.08.2021By Eric Schroeder
ST. LOUIS, MISSOURI, US — After two years of reorganizing, rightsizing the portfolio and getting the balance sheet where it needs to be — the so-called “fix” phase, Bunge Ltd. is ready to embark on the “growth” phase, said Gregory A. Heckman, chief executive officer.

The fix phase, Heckman said, was all about growing earnings and improving the underlying earning power of the business to grow off of. In the growth phase, Bunge gets to focus on expanding its footprint and building out its capabilities.


“Now we get to the fun stage, right?” Heckman told participants during the BMO Capital Markets Growth and ESG Conference held virtually on Dec. 7.

With the right network, operating model and people, Bunge is now positioned to “get maniacally focused externally,” Mr. Heckman said. This next phase for Bunge will mean “pulling every growth lever,” he added.

Specifically, Heckman said all options are on the table for growth, including organic projects, brownfield projects, greenfield projects and mergers and acquisitions of all sizes.

“Those are all open to us, and we’ll let the numbers drive where we should go,” he said.

He said M&A and debottlenecking will get to the ground more quickly, while brownfield and greenfield projects will take some time to yield contributions to earnings.

“But if you look at the refined and specialty oils platform … we’ve got the ability now to margin up some of the things that we did in commodities before,” he explained. “None of them are big, but they’re all in our adjacencies, right? So, the lecithins and the tocopherols and some of the things that we’re doing in infant nutrition also work in … senior nutrition and sports nutrition. We continue to move the ball on all those things. And as we make progress, those are all places that fit for organic investment and/or bolt-on acquisitions.”

On the plant protein side, Bunge is serving its customers and finding success with lipids, Heckman said. He also said the company has invested in its Creative Solutions Center to be able to work with not only its lipids, but also its plant proteins, and in many cases is working with customers to put those two products together.

“So as we work with those customers backwards, many of those names you know today on the existing CPGs and some of those on the disruptors and the new customers, helping them because they’re worried about long term when they see their own demand forecast that they’re going to have enough supply,” he said.

Heckman said Bunge has made some minority investments to gain access to technology and has looked at larger M&As, although the latter have traded at high prices. The plan, though, is to stay disciplined, he said.

“We think we’ll probably create value there by doing something on the brownfield or greenfield side, when it makes sense and to grow with those customers over time,” he said. “So the plant protein will be a longer build. We’ll enjoy that in the lipids now, we’ll enjoy the plant protein piece later.”

Bunge also remains fully engaged in its biggest business — supplying renewable feedstocks, including both products and services, Mr. Heckman said.

He said the company is looking at all the opportunities going forward on its renewable fuel joint venture formed in September with the Chevron Corp. As part of the JV, Bunge is expected to contribute its soybean processing facilities in Destrehan, Louisiana, US, and Cairo, Illinois, US. Chevron, San Ramon, California, US, is expected to contribute about $600 million in cash to the joint venture, which aims to establish a reliable supply chain from farmer to fueling station for both companies. The two companies anticipate approximately doubling the combined capacity of the facilities to 7,000 tons per day by the end of 2024.

“We’ll begin to look at a number of opportunities with them and possibly others that could take us from developing all of the things that are going to be important to meeting the demand on the renewable diesel side and on renewable fuels, and that will be developing cover crops,” Heckman said. “It may be building pretreatment at one of our refineries or at a different location, to develop the lowest cost model to source all of these other low CI (carbon intensity) feedstocks. Because there will be some different flows in how those work and blended into corn oils or assimilated with those to get leverage of the logistics of soy or canola oil. And we think that those are places that we’ve absolutely got a right to play. And with a partner like Chevron, we’re excited about those things developing over time.”

Moving forward, Heckman said the velocity of change and the amount of change being seen in the renewable fuels industry is like nothing ever seen before.

“I’m not sure we’ve ever seen it in our careers, and we just think, with our footprint and our operating model and our focus in this space, we’re in the best position to take advantage of that, to serve the customers on both the food, the feed and the fuel because they’re all trying to lower their CI score, and that will take us working all the way down the value chain, including with our farmer customer at the production level to change practices and to create regenerative ag,” he said.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 100

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 117

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
?atwogang Leads Tiltify's Impact Creator Class of 2026

Updated Category News Views 60

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Continue Reading
Alchemy's Texas Move: Strategic Growth or Gamble?

Updated Category News Views 80

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading

Top 5 Most Recently Viewed Articles

Boosty Labs Elevates Leadership to Fuel 2025 Vision

Updated Category News Views 170

Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...

Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions

Updated Category News Views 236

Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 172

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
Discover the Compact Keurig® K-Mini Mate™ Brewer Today

Updated Category News Views 105

Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...

Continue Reading
Explore Telix Pharmaceuticals' Latest Innovations in Urology

Updated Category News Views 179

Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...

Continue Reading